source
- Vera Therapeutics receives accelerated approval for Trutakna to treat IgA nephropathyVera Therapeutics announced that its fusion protein atacicept, branded as Trutakna, has been granted accelerated approval by the FDA for the treatment of immunoglobulin A nephropathy, a chronic aut…
- FDA grants accelerated approval to Vera Therapeutics' Trutakna for IgA nephropathyThe FDA has granted accelerated approval to Trutakna (formerly known as atacicept) from Vera Therapeutics for adult patients with IgA nephropathy, a chronic kidney disease that can progress to rena…